Payment overview · 2025
General Payments
$19.86
1 reported records · 1 companies
Healthcare provider profile · identity verified
Jeffrey G Snyder, MD
Allopathic & Osteopathic Physicians|Family Medicine · COLORADO SPRINGS, CO · NPI 1891732004
Verified facts
What the public records show
CMS Open Payments records show Jeffrey G Snyder, MD received $19.86 in general payments during 2025 across 1 reported records.
InspireMD Ltd accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| InspireMD Ltd | Unresolved — no canonical attribution shown | $19.86 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $19.86 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| CGuard Prime Carotid Stent System Normalized: cguard prime carotid stent system |
Device | InspireMD Ltd | $19.86 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 662 | 220 |
| Levothyroxine Sodium | Levothyroxine Sodium | 503 | 164 |
| Amlodipine Besylate | Amlodipine Besylate | 454 | 157 |
| Lisinopril | Lisinopril | 371 | 126 |
| Losartan Potassium | Losartan Potassium | 357 | 122 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 353 | 113 |
| Metoprolol Succinate | Metoprolol Succinate | 256 | 88 |
| Omeprazole | Omeprazole | 237 | 88 |
| Gabapentin | Gabapentin | 213 | 80 |
| Hydrochlorothiazide | Hydrochlorothiazide | 212 | 70 |
| Simvastatin | Simvastatin | 196 | 62 |
| Pantoprazole Sodium | Pantoprazole Sodium | 179 | 71 |
| Metformin Hcl | Metformin Hcl | 176 | 61 |
| Tamsulosin Hcl | Tamsulosin Hcl | 145 | 50 |
| Pravastatin Sodium | Pravastatin Sodium | 140 | 41 |
| Tramadol Hcl | Tramadol Hcl | 127 | 36 |
| Trazodone Hcl | Trazodone Hcl | 123 | 44 |
| Clopidogrel | Clopidogrel Bisulfate | 120 | 38 |
| Eliquis | Apixaban | 119 | 37 |
| Metoprolol Tartrate | Metoprolol Tartrate | 118 | 42 |
| Sertraline Hcl | Sertraline Hcl | 111 | 42 |
| Escitalopram Oxalate | Escitalopram Oxalate | 98 | 35 |
| Duloxetine Hcl | Duloxetine Hcl | 97 | 28 |
| Alprazolam | Alprazolam | 94 | 42 |
| Ezetimibe | Ezetimibe | 93 | 30 |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 92 | 89 |
| Fluticasone Propionate | Fluticasone Propionate | 86 | 50 |
| Meloxicam | Meloxicam | 83 | 34 |
| Furosemide | Furosemide | 80 | 36 |
| Metformin Hcl Er | Metformin Hcl | 79 | 33 |
| Montelukast Sodium | Montelukast Sodium | 78 | 30 |
| Famotidine | Famotidine | 72 | 29 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 72 | 23 |
| Potassium Chloride | Potassium Chloride | 71 | 28 |
| Valsartan | Valsartan | 70 | 19 |
| Jardiance | Empagliflozin | 68 | 23 |
| Sildenafil Citrate | Sildenafil Citrate | 64 | 23 |
| Zolpidem Tartrate | Zolpidem Tartrate | 64 | 27 |
| Citalopram Hbr | Citalopram Hydrobromide | 63 | 23 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 62 | 29 |
| Alendronate Sodium | Alendronate Sodium | 62 | 24 |
| Atenolol | Atenolol | 61 | 18 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 60 | 20 |
| Carvedilol | Carvedilol | 55 | 18 |
| Bupropion Xl | Bupropion Hcl | 53 | 17 |
| Finasteride | Finasteride | 53 | 17 |
| Tizanidine Hcl | Tizanidine Hcl | 52 | 23 |
| Fluoxetine Hcl | Fluoxetine Hcl | 51 | 15 |
| Allopurinol | Allopurinol | 46 | 16 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 46 | 18 |
| Buspirone Hcl | Buspirone Hcl | 45 | 21 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 45 | 13 |
| Lorazepam | Lorazepam | 45 | 15 |
| Pioglitazone Hcl | Pioglitazone Hcl | 43 | 16 |
| Warfarin Sodium | Warfarin Sodium | 43 | 17 |
| Boostrix Tdap | Diphth,pertuss(Acell),tet Vac | 42 | 41 |
| Clonazepam | Clonazepam | 42 | 13 |
| Ramipril | Ramipril | 41 | 13 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 41 | 15 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 40 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 40 | 12 |
| Glimepiride | Glimepiride | 39 | 14 |
| Ozempic | Semaglutide | 39 | 13 |
| Mirtazapine | Mirtazapine | 38 | 15 |
| Celecoxib | Celecoxib | 37 | 13 |
| Chlorthalidone | Chlorthalidone | 35 | 13 |
| Prednisone | Prednisone | 35 | 19 |
| Clonidine Hcl | Clonidine Hcl | 34 | 13 |
| Lovastatin | Lovastatin | 34 | 12 |
| Topiramate | Topiramate | 33 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 32 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 31 | suppressed |
| Januvia | Sitagliptin Phosphate | 31 | suppressed |
| Spironolactone | Spironolactone | 31 | 12 |
| Sumatriptan Succinate | Sumatriptan Succinate | 31 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 30 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 30 | 11 |
| Diclofenac Sodium | Diclofenac Sodium | 29 | 16 |
| Ondansetron Hcl | Ondansetron Hcl | 29 | suppressed |
| Primidone | Primidone | 29 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 28 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 28 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 28 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 28 | suppressed |
| Glipizide | Glipizide | 27 | 11 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 26 | 22 |
| Terazosin Hcl | Terazosin Hcl | 26 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 24 | suppressed |
| Estradiol | Estradiol | 23 | suppressed |
| Fenofibrate | Fenofibrate | 23 | suppressed |
| Mounjaro | Tirzepatide | 23 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 22 | 11 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 22 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 21 | suppressed |
| Azithromycin | Azithromycin | 20 | 19 |
| Baclofen | Baclofen | 20 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 20 | suppressed |
| Methylprednisolone | Methylprednisolone | 20 | 20 |
| Doxycycline Hyclate | Doxycycline Hyclate | 19 | 19 |
| Terbinafine Hcl | Terbinafine Hcl | 19 | 13 |
| Enalapril Maleate | Enalapril Maleate | 18 | suppressed |
| Mupirocin | Mupirocin | 18 | 16 |
| Quetiapine Fumarate | Quetiapine Fumarate | 18 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 18 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 17 | 15 |
| Ipratropium Bromide | Ipratropium Bromide | 17 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 17 | suppressed |
| Synthroid | Levothyroxine Sodium | 17 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 17 | 11 |
| Xarelto | Rivaroxaban | 17 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 16 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 16 | suppressed |
| Calcitriol | Calcitriol | 16 | suppressed |
| Eszopiclone | Eszopiclone | 16 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 16 | suppressed |
| Methocarbamol | Methocarbamol | 16 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 16 | suppressed |
| Acyclovir | Acyclovir | 15 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 15 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 15 | suppressed |
| Nifedipine Er | Nifedipine | 15 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 15 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 15 | suppressed |
| Telmisartan | Telmisartan | 15 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 15 | suppressed |
| Varenicline Tartrate | Varenicline Tartrate | 15 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 14 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 14 | suppressed |
| Sotalol | Sotalol Hcl | 14 | suppressed |
| Ursodiol | Ursodiol | 14 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 13 | suppressed |
| Digoxin | Digoxin | 13 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 13 | suppressed |
| Estradiol (Twice Weekly) | Estradiol | 13 | suppressed |
| Glipizide Er | Glipizide | 13 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 13 | suppressed |
| Pregabalin | Pregabalin | 13 | suppressed |
| Torsemide | Torsemide | 13 | suppressed |
| Aripiprazole | Aripiprazole | 12 | suppressed |
| Belsomra | Suvorexant | 12 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 12 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 12 | suppressed |
| Gemfibrozil | Gemfibrozil | 12 | suppressed |
| Ketoconazole | Ketoconazole | 12 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 12 | 12 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 12 | 11 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 12 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 11 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $19.86 · 1 records | InspireMD Ltd | CGuard Prime Carotid Stent System | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error